000250 — Sam Chun Dang Pharm Share News
0.000.00%
Last trade - 00:00- KR₩5tn
- KR₩5tn
- KR₩232bn
Brief: Sam Chun Dang Pharm Co To Buy 9.9 Billion Won Worth Of Shares In Optus Pharmaceutical
Brief: Sam Chun Dang Pharm To Divest 29.5 Billion Won Worth Of Own Shares
Brief: Sam Chun Dang Pharm To Divest 61 Billion Won Worth Of Own Shares
Brief: Sam Chun Dang Pharm Wins Exclusive Sales Rights To Supply Aflibercept Biosimilar For Treatment Of Macular Degeneration In Germany, Spain, Italy, Switzerland, Austria
Brief: Sam Chun Dang Pharm Wins Exclusive Supply And Sales Rights Of Biosimilar Treatment Scd411 For Age-Related Macular Degeneration In Canda With Canada-Based Company Apotex Inc
CEO to Yoon Dae Yin and Jeon Yin Seok
Brief: Sam Chun Dang Pharm signs contract worth 3.17 bln won
Brief: Sam Chun Dang Pharm to pay cash dividend at 50 won/share
Brief: Sam Chun Dang Pharm to pay annual dividend as 50 won/share for FY 2016
Brief: Sam Chun Dang Pharm signs 7.84 bln won contract with BPI
Brief: Sam Chun Dang Pharm says exercise of bonds with warrants into shares
Brief: Pangen Biotech signs contract worth 2.03 bln won